KY
Kyverna Therapeutics, Inc.
KYTX · NASDAQ
$6.90 -1.71% (-$0.12)
1M -18.82%
Market Cap $419.5M
P/E Ratio -
Div. Yield -
ROE 81.91%
Piotroski F-Score Weak
1/9Valuation
74 /100
Cheap P/B 2.53x
P/E N/A
EV/EBITDA N/A
Growth
100 /100
Growing Book val. growth 70.73%
EPS growth N/A
Rev. growth N/A
Profitability
-
N/A Gross margin N/A
Net margin N/A
Op. margin N/A
Quality
0 /100
Poor ROIC 80.05%
ROE 81.91%
ROA 69.44%
Debt
69 /100
Low Debt/Equity 0.20x
Current ratio 9.06x
Int. coverage -85.23x
Stability
1 /100
Unstable Beta 1.99x
EPS volatility 1,922,544.84%
Profitable years 0
Bulios Scoring popisuje kvalitu a minulost firmy, ne budoucí výnos. Vysoké skóre není nákupní signál. Zjistit více
Zeptejte se StockBota na KYTX
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Warner Biddle
Employees
149
Headquarters
Emeryville
Nadcházející události
11 LIS
Earnings
Upcoming earnings report